More about

Antipsychotic Agent

News
August 10, 2021
3 min read
Save

Medication use increased among nursing home residents during pandemic

Recent data revealed an increase in medication use among nursing home residents in Ontario, Canada, “with the potential for adverse effects” during the COVID-19 pandemic, according to researchers.

News
July 22, 2021
3 min read
Save

People with preexisting mental disorders at increased risk for COVID-19-related mortality

Preexisting mental disorders, particularly psychotic and mood disorders, as well as exposure to antipsychotics and anxiolytics, increased risk for COVID-19-related mortality.

News
July 20, 2021
2 min read
Save

Veterans’ treatment discontinuation differs by type of antipsychotic

Researchers reported differences in antipsychotic treatment discontinuation among veterans with schizophrenia in an observational study published in American Journal of Psychiatry.

News
June 29, 2021
2 min read
Save

Functional dysconnectivity 'widespread' in antipsychotic-naive first-episode psychosis

Antipsychotic-naive patients with first-episode psychosis exhibited widespread functional dysconnectivity at baseline, according to results of a secondary analysis of a randomized clinical trial published in JAMA Psychiatry.

News
May 17, 2021
1 min read
Save

Cardiometabolic marker monitoring important for patients on antipsychotics

Physicians should monitor cardiometabolic markers among patients on antipsychotics, according to results of a retrospective study presented at the American Psychiatric Association’s annual meeting.

News
May 14, 2021
2 min read
Save

Olanzapine/samidorphan treatment reduces weight gain for several schizophrenia subgroups

Olanzapine/samidorphan combination treatment reduced weight gain across several subgroups of individuals at increased risk for weight gain with olanzapine, according to results of a subgroup analysis.

News
April 19, 2021
3 min read
Save

LAIs more beneficial for certain schizophrenia outcomes than oral antipsychotics

Long-acting injectable antipsychotics provided significant benefit in prevention of hospitalization or relapse for schizophrenia compared with oral antipsychotics, according to study results published in The Lancet Psychiatry.

News
February 26, 2021
2 min read
Save

LAI formulations of paliperidone, aripiprazole, olanzapine have highest effect sizes

Long-acting injectable formulations of paliperidone, aripiprazole and olanzapine had the highest effect sizes and certainty of evidence for relapse prevention and acceptability, researchers noted in American Journal of Psychiatry.

News
January 21, 2021
1 min read
Save

LAI paliperidone use during early schizophrenia phases linked to better outcomes

Long-acting injectable paliperidone use was associated with significant improvement in clinical and functional outcomes among individuals with schizophrenia, according to study results published in Journal of Clinical Psychiatry.

News
December 16, 2020
2 min read
Save

Homeless veterans may benefit from improved prescribing of antipsychotics

Opportunities exist to improve clinicians’ antipsychotic prescribing practices for homeless or unstably housed veterans, according to study results published in Journal of Clinical Psychiatry.

View more